SAN DIEGO, Feb. 12, 2014 — Common infections are associated with a significantly higher chance of stroke in children, but routine vaccinations may help decrease risk, according to preliminary research (abstract 39) presented at the American Stroke Association’s International Stroke Conference 2014.
“The protective association of routine vaccination against childhood stroke provides a widely available means of prevention, and this information can easily be dispersed by pediatric healthcare providers,” said Nancy Hills, Ph.D., M.B.A., lead researcher and assistant professor of neurology at the University of California, San Francisco Medical Center.
The international study, Vascular effects of Infection in Pediatric Stroke (VIPS) is a prospective study examining the link between infections and ischemic stroke, the most common type of stroke. (Ischemic stroke is caused by a clot that blocks blood flow in or leading to the brain.)
Previous research by Hills and co-authors found that minor infections were related to an increased risk, but it was unclear whether infection actually could help predict future stroke.
In the VIPS study, researchers found that common infections within the past week were linked to more than six times the risk of stroke, Hills said. Seventeen percent of the stroke patients vs. 3 percent of the non-stroke patients were reported to have had any minor infection in the prior week. The most frequent types of infection were colds and other upper respiratory infections (8 percent of the stroke and 2.4 percent of the non-stroke patients reported an occurrence of these kinds of infections in the prior week).
However, routine vaccinations were associated with a lower stroke risk.
Children who had “some, few or no” routine vaccinations were 6.7 times more likely to have an ischemic stroke than those receiving “all or most” vaccines, including those against polio, measles, mumps, rubella and pneumococcus.
Researchers interviewed parents or guardians of 310 children who had a stroke to determine the presence and timing of any infectious illnesses prior to their stroke. They compared their findings with 289 children who hadn’t experienced a stroke, but had visited the doctor for an annual checkup, routine follow-up for headaches or developmental delay, or trauma.
The median age of the children who had a stroke was 7.5 years, and the median age among the comparison group was slightly more than 8.
“Because many childhood strokes appear to have no clear cause, and others likely have more than one cause, preventive measures have not been forthcoming,” Hills said. “It is very promising that childhood vaccinations appear to have a protective effect.”
In other VIPS analyses (abstracts 36 & 38) researchers found that infections with parvovirus B19 (the cause of “slapped cheek syndrome”) and different herpes viruses also were linked to a significantly greater stroke risk. Blood tests indicated that 41 percent of stroke patients had an active herpes infection, compared to 9 percent of non-stroke patients.
“VIPS is the largest-ever NIH-funded study of childhood stroke,” said Heather J. Fullerton, M.D., M.A.S., principal investigator for the VIPS study and Professor of Neurology and Pediatrics at University of California San Francisco. “These three abstracts represent the first results of this important international effort.”
Other VIPS researchers are: Gabrielle A. DeVeber, M.D., M.Sc.; Mitchell S. Elkind, M.D., M.S.; Max Wintermark, M.D.; Carol A. Glaser, M.D.; Katherine Sear, M.P.H.; Jorge M. Luna, M.P.H; W. Ian Lipkin, M.D; Kawthar Muhammad, B.A.; and Rafal Tokarz, Ph.D. Author disclosures are on the abstracts.
The VIPS study is funded by the National Institutes of Health.
VIPS represents the work of the International Pediatric Stroke Study (IPSS), a consortium of pediatric stroke investigators established in 2003 by Dr. Gabrielle DeVeber at the Hospital for Sick Children, Toronto. The 40 IPSS centers enrolling in VIPS are located on five continents and have now enrolled almost 350 cases and 350 controls — numbers that can only be achieved through a large collaborative effort like this. The VIPS study is co-lead by Fullerton and DeVeber, Hospital for Sick Children in Toronto.
Statements and conclusions of study authors that are presented at American Stroke Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.